228 related articles for article (PubMed ID: 22770721)
1. GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.
Kishi T; Ichinose H; Yoshimura R; Fukuo Y; Kitajima T; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Musso GM; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
J Affect Disord; 2012 Dec; 142(1-3):315-22. PubMed ID: 22770721
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of SIGMAR1 with major depressive disorder and SSRI response.
Kishi T; Yoshimura R; Okochi T; Fukuo Y; Kitajima T; Okumura T; Tsunoka T; Kawashima K; Yamanouchi Y; Kinoshita Y; Umene-Nakano W; Naitoh H; Nakamura J; Ozaki N; Iwata N
Neuropharmacology; 2010 Jun; 58(7):1168-73. PubMed ID: 20178807
[TBL] [Abstract][Full Text] [Related]
3. CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Tsunoka T; Ozaki N; Iwata N
Neuromolecular Med; 2009; 11(2):53-7. PubMed ID: 19347611
[TBL] [Abstract][Full Text] [Related]
4. Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.
Okuda A; Kishi T; Okochi T; Ikeda M; Kitajima T; Tsunoka T; Okumukura T; Fukuo Y; Kinoshita Y; Kawashima K; Yamanouchi Y; Inada T; Ozaki N; Iwata N
Neuromolecular Med; 2010 Mar; 12(1):78-85. PubMed ID: 19760522
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.
Tsunoka T; Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):875-9. PubMed ID: 19386277
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 gene is associated with major depressive disorder in the Japanese population.
Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Fukuo Y; Naitoh H; Umene-Nakano W; Inada T; Nakamura J; Ozaki N; Iwata N
J Affect Disord; 2010 Oct; 126(1-2):167-73. PubMed ID: 20451257
[TBL] [Abstract][Full Text] [Related]
7. Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.
Fukuo Y; Kishi T; Kushima I; Yoshimura R; Okochi T; Kitajima T; Matsunaga S; Kawashima K; Umene-Nakano W; Naitoh H; Inada T; Nakamura J; Ozaki N; Iwata N
J Affect Disord; 2011 Sep; 133(1-2):150-7. PubMed ID: 21663972
[TBL] [Abstract][Full Text] [Related]
8. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
9. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
[TBL] [Abstract][Full Text] [Related]
10. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population.
Kishi T; Fukuo Y; Yoshimura R; Okochi T; Kitajima T; Naitoh H; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
Hum Psychopharmacol; 2010 Aug; 25(6):481-6. PubMed ID: 20737521
[TBL] [Abstract][Full Text] [Related]
12. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
[TBL] [Abstract][Full Text] [Related]
13. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.
Wang HC; Yeh TL; Chang HH; Gean PW; Chi MH; Yang YK; Lu RB; Chen PS
Psychopharmacology (Berl); 2011 Feb; 213(4):773-9. PubMed ID: 20945066
[TBL] [Abstract][Full Text] [Related]
14. Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients.
Saito S; Takahashi N; Ishihara R; Ikeda M; Suzuki T; Kitajima T; Yamanouchi Y; Iwata N; Yamada M; Yoshida K; Inada T; Ozaki N
Neuropsychobiology; 2006; 54(4):226-30. PubMed ID: 17356306
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.
Kato M; Wakeno M; Okugawa G; Fukuda T; Takekita Y; Hosoi Y; Azuma J; Kinoshita T; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1041-4. PubMed ID: 18325652
[TBL] [Abstract][Full Text] [Related]
16. Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.
Sato K; Yoshida K; Takahashi H; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
Neuropsychobiology; 2002; 46(3):136-40. PubMed ID: 12422060
[TBL] [Abstract][Full Text] [Related]
17. Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.
Takahashi H; Yoshida K; Higuchi H; Kamata M; Inoue K; Suzuki T; Ishigooka J
Neuropsychobiology; 2014; 70(3):173-80. PubMed ID: 25358426
[TBL] [Abstract][Full Text] [Related]
18. Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population.
Kim SK; Kim SH; Nah SS; Lee JH; Hong SJ; Kim HS; Lee HS; Kim HA; Joung CI; Bae J; Choe JY; Lee SS
J Rheumatol; 2013 Mar; 40(3):316-22. PubMed ID: 23322459
[TBL] [Abstract][Full Text] [Related]
19. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
20. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Tsunoka T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
Neurosci Res; 2009 Jun; 64(2):231-4. PubMed ID: 19428704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
